USANA Health Sciences (USNA) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
3 Feb, 2026Executive summary
Q2 2024 net sales declined 10.6%–11% year-over-year to $212.9–$213 million, with diluted EPS down 39% to $0.54 and active customers falling 3.9%–4% to 468,000, driven by lower customer counts, reduced promotional activity, and macroeconomic pressures.
Net earnings for Q2 2024 were $10.4 million, down 39.7% from the prior year, due to decreased sales, higher operating expenses, and a higher effective tax rate.
Strategic initiatives include commercial team restructuring, product innovation, India expansion, M&A, and increased associate engagement.
Leadership strengthened with new EVP of R&D and promotion of China GM to drive growth.
Balance sheet remains strong with $332–$332.4 million in cash, zero debt, and $8 million in Q2 operating cash flow.
Financial highlights
Gross margin for Q2 2024 was 81.1% of net sales, down 70 basis points year-over-year due to FX and lower sales leverage.
Operating margin for the first half was around 9.5%–9.6%, with FY24 guidance revised to 8.0%–8.8%.
Diluted EPS for Q2 2024 was $0.54, a 39%–39.3% decrease from the prior year.
Cash and cash equivalents increased to $332.4 million as of June 29, 2024.
No share repurchases in Q2; $61.7–$62 million remains authorized.
Outlook and guidance
FY24 net sales outlook revised to $850–$880 million, with diluted EPS guidance at $2.40–$2.55.
Net sales expected to be negatively impacted by ~$20 million from FX for FY24.
Annual effective tax rate now expected at 43–44%.
Second half sales expected to be flat to down mid-single digits, with operating margin below 9% due to ongoing investments.
Management believes current liquidity is adequate to meet cash requirements and sustain operations.
Latest events from USANA Health Sciences
- 2026 outlook targets 4%–8% sales growth, led by retail expansion and strategic investments.USNA
Q4 202518 Feb 2026 - Hiya acquisition and agile innovation drive growth, with China and global markets as key priorities.USNA
Sidoti Small-Cap Virtual Conference3 Feb 2026 - Active associate growth and accelerated product innovation drive global expansion and future growth.USNA
Small-Cap Growth Virtual Investor Conference1 Feb 2026 - China drives short-term gains as focus shifts to associates, innovation, and disciplined growth.USNA
Water Tower Research Consumer Products Virtual Investor Conference 20241 Feb 2026 - Q3 2024 net sales declined 6.2% year-over-year, with EPS at $0.56 and cash at $365M.USNA
Q3 202419 Jan 2026 - Omnichannel brands and retail expansion are driving rapid growth and diversification.USNA
28th Annual ICR Conference 202612 Jan 2026 - $205M acquisition of a children's wellness brand accelerates growth and market leadership.USNA
M&A Announcement10 Jan 2026 - Acquisition of Hiya Health accelerates growth in children's supplements and expands market reach.USNA
27th Annual ICR Conference 202510 Jan 2026 - Q1 2025 net sales up 9.5–12% to $249.5M, but net earnings fell 43% to $9.4M.USNA
Q1 202527 Dec 2025